CV Sciences (CVSI) Other Non-Current Assets (2013 - 2026)
CV Sciences' (CVSI) quarterly Other Non-Current Assets came in at $47000.0 in Q1 2026, down 52.53% year-on-year from $99000.0 in Q1 2025, and little changed quarter-over-quarter from $47000.0 in Q4 2025.
CV Sciences (CVSI) Other Non-Current Assets (2013 - 2026) Analysis & Trends
CV Sciences has disclosed Other Non-Current Assets across 14 years of filings, most recently posting $47000.0 for Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $47000.0, down 52.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $47000.0 (down 52.53% YoY), and the FY2025 annual result was $47000.0, changed N/A from the prior year.
- Other Non-Current Assets came in at $47000.0 for Q1 2026 at CV Sciences, roughly flat from $47000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $626000.0 in Q1 2022 to a low of $47000.0 in Q3 2025.
- The 5-year median for Other Non-Current Assets is $244000.0 (2024), against an average of $294066.7.
- Across the five-year window, Other Non-Current Assets grew 24.95% in 2022 and tumbled 69.48% in 2025, its largest moves.
- CV Sciences' Other Non-Current Assets stood at $505000.0 in 2022, then tumbled by 31.09% to $348000.0 in 2023, then slumped by 55.75% to $154000.0 in 2024, then sank by 69.48% to $47000.0 in 2025, then changed by 0.0% to $47000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $47000.0 (Q1 2026), $47000.0 (Q4 2025), and $47000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 47.63 Mn |
| 10 | CV Sciences | - | - | 1.56 Mn | 47,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47,000.00 |
| Dec 31, 2025 | 47,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Jun 30, 2025 | 72,000.00 |
| Mar 31, 2025 | 99,000.00 |
| Sep 30, 2024 | 154,000.00 |
| Jun 30, 2024 | 202,000.00 |
| Mar 31, 2024 | 244,000.00 |
| Sep 30, 2023 | 348,000.00 |
| Jun 30, 2023 | 401,000.00 |
| Mar 31, 2023 | 452,000.00 |
| Dec 31, 2022 | 505,000.00 |
| Sep 30, 2022 | 557,000.00 |
| Jun 30, 2022 | 610,000.00 |
| Mar 31, 2022 | 626,000.00 |
| Dec 31, 2021 | 678,000.00 |
| Sep 30, 2021 | 730,000.00 |
| Jun 30, 2021 | 501,000.00 |
| Mar 31, 2021 | 501,000.00 |
| Dec 31, 2020 | 500,000.00 |